You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AMN107

Showing 1 - 25 of 79
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia Trial in New York (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • New York, New York
    Weill Cornell Medical College
Mar 24, 2022

Chordoma Trial in Boston (Nilotinib, Radiation therapy)

Active, not recruiting
  • Chordoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 27, 2021

Chronic Myelogenous Leukemia Trial in Beirut (Nilotinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Beirut, Lebanon
    American University of Beirut Medical Center
Feb 14, 2022

Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (Biopsy, Biospecimen Collection, Computed Tomography)

Not yet recruiting
  • Metastatic Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Biopsy
  • +5 more
  • (no location specified)
Nov 8, 2022

Gastrointestinal Stromal Tumors Trial in Worldwide (AMN107, STI571)

Completed
  • Gastrointestinal Stromal Tumors
  • AMN107, STI571
  • Boston, Massachusetts
  • +4 more
Dec 6, 2020

Chronic Phase Chronic Myeloid Leukemia Trial in Bruxelles (Ponatinib 30 mg QD, Ponatinib 15 mg QD, Nilotinib 400 mg BID)

Terminated
Has Results
  • Chronic Phase Chronic Myeloid Leukemia
  • Ponatinib 30 mg QD
  • +2 more
  • Bruxelles, Belgium
    Cliniques Universitaire Saint-Luc (Site 058)
Oct 28, 2021

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive) Trial in Tokyo (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)
  • Tokyo, Japan
    Novartis Investigative Site
Dec 6, 2020

CML, Philadelphia Chromosome Positive (Ph+), Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib

Terminated
Has Results
  • CML
  • +2 more
  • Las Vegas, Nevada
  • +2 more
Apr 28, 2021

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Recruiting
  • Anatomic Stage I Breast Cancer AJCC v8
  • +19 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Mar 19, 2021

Chronic GVHD Trial in Israel, Italy (nilotinib)

Completed
  • Chronic Graft Versus Host Disease
  • Tel Hashomer, Israel
  • +11 more
Aug 19, 2021

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Aichi (Nilotinib)

Completed
  • Chronic Myelogenous Leukemia
  • Acute Lymphoblastic Leukemia
  • Aichi, Japan
    Novartis Investigative Site
Dec 6, 2020

GIST and CML Trial in Worldwide (AMN107)

Active, not recruiting
  • GIST and CML
  • Albany, New York
  • +32 more
Oct 4, 2022

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Locally Advanced Malignant Solid Neoplasm
  • (no location specified)
Dec 2, 2022

Chronic Myelogenous Leukemia - Chronic Phase Trial in United States (Nilotinib)

Terminated
Has Results
  • Chronic Myelogenous Leukemia - Chronic Phase
  • Los Angeles, California
  • +10 more
Jul 26, 2021

Chronic Myeloid Leukemia Trial in Germany, United Kingdom (Tasigna)

Completed
  • Chronic Myeloid Leukemia
  • Frankfurt/M, Germany
  • +4 more
Dec 6, 2020

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual

Terminated
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2020

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Asciminib single agent
  • +5 more
  • Ann Arbor, Michigan
  • +49 more
Jan 26, 2023

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Worldwide (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Acute Lymphoblastic Leukemia
  • Bordeaux, Aquitaine, France
  • +11 more
Dec 6, 2020

Chronic Myeloid Leukemia Trial in Germany (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Mannheim, Baden-Wuerttemberg, Germany
  • +69 more
Mar 21, 2022

Chronic Myelogenous Leukemia Trial in Turkey (Nilotinib)

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • Eskisehir, Meselik, Turkey
  • +12 more
Aug 18, 2020

Leukemia Trial in Houston (MEK-162, Nilotinib, Questionnaires)

Terminated
  • Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 10, 2020

Chronic Myelogenous Leukemia Trial in Canada, United States (Nilotinib)

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • Fayetteville, Arkansas
  • +22 more
Jun 29, 2021

Bone Marrow Transplant Failure, Lymphoma, Non-Hodgkin, Lymphoma, T-Cell, Peripheral Trial in Canada, United States (Nilotinib)

Completed
  • Bone Marrow Transplant Failure
  • +2 more
  • Stanford, California
  • +4 more
Apr 13, 2020

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive), Hypereosinophilic Syndrome Trial

Completed
Has Results
  • Chronic Myelogenous Leukemia
  • +3 more
  • Duarte, California
  • +100 more
Jun 8, 2021